Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Gain Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Exercised 825 restricted stock units @ $0
07/05/2023 4 Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Exercised 3,300 restricted stock units @ $0
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 3 Fuggetta Gianluca (Principal Accounting Officer) has filed a Form 3 on Gain Therapeutics, Inc.
09/22/2022 4 RICHMAN ERIC I (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 329,400 options to buy @ $3.5, valued at $1.2M
Granted 54,900 restricted stock units @ $0
09/22/2022 4 Islam Khalid (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Riley Jeffrey Scott (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Nicaise Claude (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 HASLER HANS PETER (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Alder Matthias (COO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 60,900 options to buy @ $3.5, valued at $213.2k
Granted 10,200 restricted stock units @ $0
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 2,482 shares @ $2.58, valued at $6.4k
05/23/2022 4 RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 4,000 shares @ $2.71, valued at $10.8k
Bought 9,256 shares @ $2.83, valued at $26.2k
05/23/2022 4/A Calabrese Salvatore (CFO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 3,000 shares @ $2.7, valued at $8.1k
04/21/2022 4/A RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 4,922 shares @ $7.866, valued at $38.7k
04/21/2022 3/A RICHMAN ERIC I (CEO) has filed a Form 3/A on Gain Therapeutics, Inc.
12/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2021 3 Bellotto Manolo (President and General Manager) has filed a Form 3 on Gain Therapeutics, Inc.
03/29/2021 3 Calabrese Salvatore (CFO) has filed a Form 3 on Gain Therapeutics, Inc.
03/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/17/2021 3 GOLDSTEIN DOV A MD (Director) has filed a Form 3 on Gain Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy